Skip to contentS
Sanara MedTech Inc.
S
SMTISanara MedTech Inc. Q4 2014 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$726.88K$726.88Kderived+56.9% vs Q4 2013 Net Income-$110.52K-$110.52KderivedN/M vs Q4 2013 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sanara MedTech Inc. · CIK 714256 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$596,586+68.5% Operating Cash Flowderived-$312,438N/M Free Cash Flowderived-$314,955N/M Margins · derivedGross margin82.1%+5.7 pt vs Q4 2013
Net margin-15.2%+305.6 pt vs Q4 2013
ended Dec 31, 2014 · filed Apr 9, 2015 · 99 d after period end